Laurent Pharma to participate to Biotech Showcase
Laurent Pharma to participate to Biotech Showcase, January 13-15, 2025, San Francisco, CA, USA
Laurent Pharmaceuticals annonces publication of results from Phase 2 study of LAU-7b for the treatment of CF in the Journal of Cystic Fibrosis
Laurent Pharmaceuticals, Inc., a Montreal-based biopharmaceutical company, today announced the publication in the peer-reviewed Journal of Cystic Fibrosis of previously disclosed results from its Phase 2 study of LAU-7b for the treatment…
Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference
Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA